Berman Capital Advisors’s Genmab GMAB Stock Holding History

Berman Capital Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$38K	Buy	894 +130	+17%	+$5.84K	0.01%	781
2021 Q2	$31K	Hold	764	–	–	﹤0.01%	758
2021 Q1	$25K	Buy	764 +53	+7%	+$1.99K	0.01%	712
2020 Q4	$28K	Hold	711	–	–	0.01%	571
2020 Q3	$26K	Hold	711	–	–	0.01%	507
2020 Q2	$23K	Buy	711 +31	+5%	+$845	0.01%	505
2020 Q1	$13K	Buy	680 +150	+28%	+$3.34K	﹤0.01%	602
2019 Q4	$11K	Hold	530	–	–	﹤0.01%	701
2019 Q3	$10K	Buy	+530	New	+$10.4K	﹤0.01%	711

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Berman Capital Advisors's GMAB Position: Q3 2021 in Review

Berman Capital Advisors increased its Genmab (GMAB) stake by 17% in Q3 2021, buying an estimated $5.84K and bringing the position to 894 shares worth $38K. The position accounts for 0.01% of the portfolio, ranked #781.

Berman Capital Advisors first reported a position in GMAB in Q3 2019 and has held it in 9 quarters since. 212 funds tracked by Wall St. Rank hold GMAB as of Q3 2021.

Berman Capital Advisors held 894 shares of Genmab worth $38K as of Q3 2021.
Berman Capital Advisors bought 130 Genmab shares in Q3 2021, an estimated $5.84K.
Genmab made up 0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #781 holding.
Berman Capital Advisors first reported a position in Genmab in Q3 2019 and has held it in 9 quarters since.
212 funds tracked by Wall St. Rank held Genmab as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.